Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lisa Durkin
SLAMF7 (CD319/CS1) Is Expressed in Plasmablastic Lymphoma and Is a Potential Diagnostic Marker and Therapeutic Target
British Journal of Haematology
Hematology
Related publications
BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
PLoS ONE
Multidisciplinary
Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma
Journal of Cancer
Oncology
CD83 Is a New Potential Biomarker and Therapeutic Target for Hodgkin Lymphoma
Haematologica
Hematology
Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
B7-H3, a Potential Therapeutic Target, Is Expressed in Diffuse Intrinsic Pontine Glioma
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
CD200 Is Induced by ERK and Is a Potential Therapeutic Target in Melanoma
Journal of Clinical Investigation
Medicine
MERTK Is a Potential Therapeutic Target in Malignant Melanoma
Cancer Discovery
Oncology
Kir3dl2 Is Expressed in Peripheral T-Cell Lymphomas and May Be a Therapeutic Target
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology